U.S., May 15 -- ClinicalTrials.gov registry received information related to the study (NCT07588074) titled 'Tolerability Comparison of Flarex to Lotemax SM' on May 08.
Brief Summary: This study compared the ocular tolerability of fluorometholone acetate ophthalmic suspension 0.1% (FLAREX) to loteprednol etabonate ophthalmic gel 0.38% (Lotemax SM) in adult subjects. Each subject received one drop of each product, one in each eye, in a randomized, double-masked design. Comfort, impact on vision, and palpebral conjunctival injection were evaluated at 30 seconds, 5 minutes, and 10 minutes after instillation.
Study Start Date: May 01, 2021
Study Type: INTERVENTIONAL
Condition:
Ocular Inflammation
Keratoconjunctivitis
Dry Eye Disease (DED)
P...